Abstract
Nineteen patients with Fanconi anemia (FA) and bone marrow failure underwent bone marrow transplantation (BMT) from matched siblings. Median age at BMT was 8.7 years. Conditioning consisted of low-dose cyclophosphamide (CY 5 mg/kg × 4 days) and thoracoabdominal irradiation (TAI 400 cGy). Graft-versus-host disease (GVHD) prophylaxis was cyclosporin A (CsA) in 13 patients and CsA plus methotrexate in 6 patients. Antithymocyte globulin (ATG) was added in the pretransplant as well as the post-transplant period. All patients received high-dose acyclovir from day 2 pre-BMT to day 28 post BMT, and intravenous immunoglobulins (IVIG), 500 mg/kg weekly from day 7 pre-BMT to day 90 post BMT. No fungal prophylaxis was given. All patients engrafted, (median, 14 days for an absolute neutrophil count ⩾0.5 × 109/l; median, 37 days for platelet count ⩾20 × 109/l). Fourteen (74%) patients are alive with sustained engraftment and are transfusion independent. Three (16.6%) patients developed acute GVHD; none developed chronic GVHD. Five (26%) patients developed invasive fungal infections, and two (10%) developed fatal CMV disease. We believe the addition of ATG may have contributed to the increased incidence of severe life-threatening fungal and viral infections in our series. Bone Marrow Transplantation (2001) 27, 139–143.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Auerbach AD, Allen RG . Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the international Fanconi anemia registry Cancer Genet Cytogenet 1991 51: 1–12
Alter BP, Young NS . The bone marrow failure syndromes In: Nathan DG, Oski FA (eds). Hematology of Infancy and Childhood, Vol 1 Saunders: Philadelphia, PA 1998 pp 259–272
Alter B . Fanconi's anemia, current concepts Am J Pediatr Hematol Oncol 1992 14: 170–184
Alter B . Fanconi's anemia and its variability Br J Haematol 1993 85: 9–14
Liu JM, Buchwald M, Walsh CE, Young NS . Fanconi anemia and novel strategies for therapy Blood 1994 84: 3995–4007
Butturini A, Gale RP, Verlander PC et al. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study Blood 1994 84: 1650–1655
Gluckman E, Berger R, Dutreix J . Bone marrow transplantation for Fanconi anemia Semin Hematol 1984 21: 20–26
Gluckman E . Allogeneic bone marrow transplantation in Fanconi anemia Bone Marrow Transplant 1996 18: (Suppl. 3) 33–35
Gluckman E, Devergie A, Schaison G et al. Bone marrow transplantation in Fanconi anaemia Br J Haematol 1980 45: 557–564
Kohli-Kumar M, Morris C, DeLaat C et al. Bone marrow transplantation in Fanconi anemia using matched sibling donors Blood 1994 84: 2050–2054
Medeiros CR, Zanis-Neto J, Pasquini R . Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning Bone Marrow Transplant 1999 24: 849–852
Zwaan C, Van Weel-Sipman M, Fibbe W et al. Unrelated donor bone marrow transplantation in Fanconi anaemia: the Leiden experience Bone Marrow Transplant 1998 21: 447–453
Socié G, Devergie A, Girinski T et al. Transplantation for Fanconi's anaemia: long term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning Br J Haematol 1998 103: 249–255
Zanis-Neto J, Ribeiro RC, Medeiros C et al. Bone marrow transplantation for patients with Fanconi anemia: a study of 24 cases from a single institution Bone Marrow Transplant 1995 15: 293–298
Yabe M, Yabe H, Matsuda M et al. Bone marrow transplantation for Fanconi anemia, adjustment of the dose of cyclophosphamide for preconditioning Am J Pediatr Hematol Oncol 1993 15: 377–382
Flowers M, Doney KC, Storb R et al. Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience Bone Marrow Transplant 1992 9: 167–173
Flowers M, Zanis J, Pasquini R et al. Marrow transplantation for Fanconi anaemia: conditioning with reduced doses of cyclophosphamide without radiation Br J Haematol 1996 92: 699–706
Gluckman E, Auerbach A . D, Horowitz M et al. Bone marrow transplantation for Fanconi anemia Blood 1995 86: 2856–2862
Storb R, Deeg HJ, Pepe M et al. Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial Br J Haematol 1989 72: 567–572
Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation (second of two parts) New Engl J Med 1975 292: 895–902
Ferretti GA, Ash RC, Brown AT et al. Chlorhexidine for prophylaxis against oral infectious and associated complications in patients receiving bone marrow transplantation J Am Dent Assoc 1987 114: 461–467
Berger R, Bernheim A, Gluckman E, Gisselbrecht C . In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anaemia patients Br J Haematol 1980 45: 565–568
Gluckman E, Devergie A, Dutreix J . Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation Br J Haematol 1983 54: 431–440
Gluckman E . Radiosensitivity in Fanconi anemia: application to the conditioning for bone marrow transplantation Radiother Oncol 1990 18: (Suppl. 1) 88–93
Hibberd P, Tolkoff-Rubin N, Conti D et al. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in antibody-positive renal transplant recipients Ann Intern Med 1995 123: 18–26
Pascual M, Rubin R, Cosimi A . Minimizing the toxicity of antilymphocyte antibody therapy Transplant Proc 1996 28: 2113–2114
Cano LE, Singer-Vermes LM, Costa TA et al. Depletion of CD8 (+) T cells in vivo impairs host defense of mice resistant and susceptible to pulmonary paracoccidioidomycosis Infect Immun 2000 68: 352–359
Teramura M, Kobayashi S, Iwabe K et al. Mechanism of action of antithymocyte globulin in the treatment of aplastic anaemia: in vitro evidence for the presence of immunosuppressive mechanism Br J Haematol 1997 96: 80–84
Socié G, Henry-Amar M, Cosset JM et al. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia Blood 1991 74: 277–275
Pierga JY, Socie G, Gluckman E et al. Secondary solid malignant tumors occurring after bone marrow transplantation for severe aplastic anemia given thoraco-abdominal irradiation Radiother Oncol 1994 30: 55–58
Deeg HJ, Socié G, Schoch G et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients Blood 1996 87: 386–392
Acknowledgements
We are extremely grateful to Dr Robert Stuart, (chairman of the Department of Oncology at the King Faisal Specialist Hospital) for his critical review of this manuscript. We are also grateful to Mrs Saada Mansour (clinical research coordinator) and to Mrs Cynthia Magpantay (research data analyst) for their excellent assistance in the data collection and analysis.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ayas, M., Solh, H., Mustafa, M. et al. Bone marrow transplantation from matched siblings in patients with Fanconi anemia utilizing low-dose cyclophosphamide, thoracoabdominal radiation and antithymocyte globulin. Bone Marrow Transplant 27, 139–143 (2001). https://doi.org/10.1038/sj.bmt.1702754
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702754